Literature DB >> 10398104

Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.

A Tannapfel1, F Geissler, F Köckerling, A Katalinic, J Hauss, C Wittekind.   

Abstract

The prognosis of patients with resectable hepatocellular carcinoma depends mainly on the anatomical extent of the tumour and on the general condition of the patient. Given the growing evidence that proliferation indices may be of prognostic significance in hepatocellular carcinomas and that parameters of cell loss (usually, but not exclusively, due to programmed cell death) are biologically relevant, the identification and quantitation of proliferative capacity and apoptosis may be of prognostic importance. In this study four different methods have been used to assess proliferation in a series of 193 curatively (R0) resected hepatocellular carcinomas: mitotic count, immunohistochemical assessment of MIB-1 (Ki-67), proliferating cell nuclear antigen (PCNA), and silver-stained nucleolar organizer regions (AgNORs). Apoptosis was assessed using the in situ-end labelling (ISEL) technique in combination with morphological criteria. Patients who received liver transplantation were excluded. The results obtained were compared with histopathological stage (according to UICC), Edmondson grade, several other histopathological factors, and survival rate. Significant statistical correlations were seen between the mitotic index, the rate of nuclear positivity for MIB-1 and PCNA, and the number of AgNOR dots. In univariate survival analysis, tumour stage and Edmondson grade, mitotic index, MIB-1 and PCNA index, and mean AgNOR number were significant factors influencing patients' survival. On multivariate Cox survival analysis, mitotix index, concomitant cirrhosis, Edmondson grade, and patient age were the only significant independent prognostic factors. Apoptosis was not related to prognosis or to other parameters examined. These results indicated that mitotic index is an additional prognostic parameter which could provide auxiliary information for patients' outcome. MIB-1 and PCNA immunostaining and AgNORs showed a good correlation among themselves. Apoptosis did not predict prognosis in hepatocellular carcinoma. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10398104     DOI: 10.1002/(SICI)1096-9896(199903)187:4<439::AID-PATH272>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.

Authors:  H Kirimlioglu; I Dvorchick; K Ruppert; S Finkelstein; J W Marsh; S Iwatsuki; A Bonham; B Carr; M Nalesnik; G Michalopoulos; T Starzl; J Fung; A Demetris
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

2.  Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.

Authors:  A Tannapfel; L Weinans; F Geissler; A Schütz; A Katalinic; F Köckerling; J Hauss; C Wittekind
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

3.  Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation.

Authors:  J T Nhieu; C A Renard; Y Wei; D Cherqui; E S Zafrani; M A Buendia
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

4.  [Effectiveness of radiofrequency ablation of lung tumours ].

Authors:  K-H Schultheis; R Schroeder-Finckh; A Schultheis; R Kappes; F Sommerer; A Tannapfel
Journal:  Chirurg       Date:  2008-10       Impact factor: 0.955

5.  Characterisation of the progression of azaserine-induced rat pancreatic adenocarcinoma by proliferative cell nuclear antigen, basement membrane laminin and trypsinogen immunohistochemistry.

Authors:  Krisztina Nagy; Zsolt Pálfia; Gábor Réz
Journal:  Histochem Cell Biol       Date:  2003-05-13       Impact factor: 4.304

6.  Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach.

Authors:  Thilo Bluethner; Manuel Niederhagen; Karel Caca; Frederik Serr; Helmut Witzigmann; Christian Moebius; Joachim Mossner; Marcus Wiedmann
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

7.  Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors.

Authors:  Martin Haefner; Thilo Bluethner; Manuel Niederhagen; Christian Moebius; Christian Wittekind; Joachim Mossner; Karel Caca; Marcus Wiedmann
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

8.  Inhibitory effect of voluntary running wheel exercise on the growth of human pancreatic Panc-1 and prostate PC-3 xenograft tumors in immunodeficient mice.

Authors:  Xi Zheng; Xiao-Xing Cui; Mou-Tuan Huang; Yue Liu; Weichung Joe Shih; Yong Lin; Yao Ping Lu; George C Wagner; Allan H Conney
Journal:  Oncol Rep       Date:  2008-06       Impact factor: 3.906

9.  Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.

Authors:  Atsushi Nanashima; Kenji Tanaka; Hiroyuki Yamaguchi; Shinichi Shibasaki; Shigeyuki Morino; Megumi Yoshinaga; Terumitsu Sawai; Tohru Nakagoe; Hiroyoshi Ayabe
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

10.  Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?

Authors:  Elisabeth Smolle; Evelyn Zöhrer; Kira Bettermann; Johannes Haybaeck
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.